CGMAB Trademark

Trademark Overview


On Wednesday, December 19, 2018, a trademark application was filed for CGMAB with the United States Patent and Trademark Office. The USPTO has given the CGMAB trademark a serial number of 88234725. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 1, 2021. This trademark is owned by Phanes Therapeutics, Inc.. The CGMAB trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development services in the field of antibodies; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; medical and scientific research in the field of cancer treatment and diagnosis; technical research in the field of pharmaceutical studies; research on the subject of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development; pharmaceutical products development; pharmaceutical product evaluation; development of pharmaceutical preparations and medicines; conducting early evaluations in the field of new pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; chemical, biochemical, biological and bacteriological research and analysis; biological research; scientific study and research in the fields of medicine, the prevention, treatment and management of illness, health care delivery; technology research in the field of p...
cgmab

General Information


Serial Number88234725
Word MarkCGMAB
Filing DateWednesday, December 19, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 1, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 30, 2019

Trademark Statements


Goods and ServicesResearch and development services in the field of antibodies; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; medical and scientific research in the field of cancer treatment and diagnosis; technical research in the field of pharmaceutical studies; research on the subject of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development; pharmaceutical products development; pharmaceutical product evaluation; development of pharmaceutical preparations and medicines; conducting early evaluations in the field of new pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; chemical, biochemical, biological and bacteriological research and analysis; biological research; scientific study and research in the fields of medicine, the prevention, treatment and management of illness, health care delivery; technology research in the field of pharmaceutical research and development; research and development in the field of medicine, the prevention, treatment and management of illness, health care delivery; medical research; medical laboratories; medical and scientific research in the field of medicine, the prevention, treatment and management of illness, health care delivery
Pseudo MarkC GM AB

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 11, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePhanes Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NamePhanes Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Monday, February 1, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 1, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, May 20, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 18, 2020EXTENSION 2 GRANTED
Monday, May 18, 2020EXTENSION 2 FILED
Monday, May 18, 2020TEAS EXTENSION RECEIVED
Monday, March 23, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 23, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 23, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 23, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 23, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 17, 2019EXTENSION 1 GRANTED
Tuesday, December 17, 2019EXTENSION 1 FILED
Tuesday, December 17, 2019TEAS EXTENSION RECEIVED
Tuesday, June 25, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 30, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 30, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 10, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 15, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 15, 2019ASSIGNED TO EXAMINER
Friday, January 11, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 22, 2018NEW APPLICATION ENTERED IN TRAM